Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.

por de Bree, R., Roos, J. C., Plaizier, M. A., Quak, J. J., van Kamp, G. J., den Hollander, W., Snow, G. B., van Dongen, G. A.
Publicado 1997